Segment disclosures

Company overview

GINKGO BIOWORKS HOLDINGS, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

8 dimension combinations 76 retained observations 18 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Biosecurity Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=dna:BiosecuritySegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3018254000 USD20231108Open filing evidence
2023-01-01 – 2023-09-30100145000 USD20231108Open filing evidence
2022-07-01 – 2022-09-3041719000 USD20231108Open filing evidence
2022-01-01 – 2022-09-30289012000 USD20231108Open filing evidence

Operating Segments · Cell Engineering Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=dna:CellEngineeringSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3037176000 USD20231108Open filing evidence
2023-01-01 – 2023-09-30116555000 USD20231108Open filing evidence
2022-07-01 – 2022-09-3024679000 USD20231108Open filing evidence
2022-01-01 – 2022-09-3090409000 USD20231108Open filing evidence

Product · Biosecurity Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=dna:BiosecuritySegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2023-01-01 – 2023-12-3128949000 USD20260226Open filing evidence
2022-01-01 – 2022-12-3135455000 USD20250225Open filing evidence

Service · Biosecurity Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=dna:BiosecuritySegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3137409000 USD20260226Open filing evidence
2024-01-01 – 2024-12-3153071000 USD20260226Open filing evidence
2023-01-01 – 2023-12-3178975000 USD20260226Open filing evidence
2022-01-01 – 2022-12-31298585000 USD20250225Open filing evidence

Biosecurity Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dna:BiosecuritySegmentMember
PeriodValueUnitFiledEvidence
2025-07-01 – 2025-09-309457000 USD20251106Open filing evidence
2025-01-01 – 2025-09-3030015000 USD20251106Open filing evidence
2025-04-01 – 2025-06-3010470000 USD20250807Open filing evidence
2025-01-01 – 2025-06-3020558000 USD20250807Open filing evidence
2025-01-01 – 2025-03-3110088000 USD20250506Open filing evidence
2024-07-01 – 2024-09-3013957000 USD20251106Open filing evidence
2024-01-01 – 2024-09-3044013000 USD20251106Open filing evidence
2024-04-01 – 2024-06-3020001000 USD20250807Open filing evidence
2024-01-01 – 2024-06-3030056000 USD20250807Open filing evidence
2024-01-01 – 2024-03-3110055000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31107924000 USD20240229Open filing evidence
2023-07-01 – 2023-09-3018254000 USD20241112Open filing evidence
2023-01-01 – 2023-09-30100145000 USD20241112Open filing evidence
2023-04-01 – 2023-06-3035285000 USD20240808Open filing evidence
2023-01-01 – 2023-06-3081891000 USD20240808Open filing evidence
2023-01-01 – 2023-03-3146606000 USD20240509Open filing evidence
2022-01-01 – 2022-12-31334040000 USD20240229Open filing evidence
2021-01-01 – 2021-12-31200848000 USD20240229Open filing evidence

Cell Engineering And Biosecurity Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dna:CellEngineeringAndBiosecuritySegmentsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-3089046000 USD20241112Open filing evidence
2024-01-01 – 2024-09-30183196000 USD20241112Open filing evidence
2024-04-01 – 2024-06-3056206000 USD20240808Open filing evidence
2024-01-01 – 2024-06-3094150000 USD20240808Open filing evidence
2024-01-01 – 2024-03-3137944000 USD20240509Open filing evidence
2023-07-01 – 2023-09-3055430000 USD20241112Open filing evidence
2023-01-01 – 2023-09-30216700000 USD20241112Open filing evidence
2023-04-01 – 2023-06-3080568000 USD20240808Open filing evidence
2023-01-01 – 2023-06-30161270000 USD20240808Open filing evidence
2023-01-01 – 2023-03-3180702000 USD20240509Open filing evidence
2022-07-01 – 2022-09-3066398000 USD20231108Open filing evidence
2022-01-01 – 2022-09-30379421000 USD20231108Open filing evidence

Cell Engineering Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dna:CellEngineeringSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31132746000 USD20260226Open filing evidence
2025-07-01 – 2025-09-3029380000 USD20251106Open filing evidence
2025-01-01 – 2025-09-30106744000 USD20251106Open filing evidence
2025-04-01 – 2025-06-3039134000 USD20250807Open filing evidence
2025-01-01 – 2025-06-3077364000 USD20250807Open filing evidence
2025-01-01 – 2025-03-3138230000 USD20250506Open filing evidence
2024-01-01 – 2024-12-31173972000 USD20260226Open filing evidence
2024-07-01 – 2024-09-3075089000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30139183000 USD20251106Open filing evidence
2024-04-01 – 2024-06-3036205000 USD20250807Open filing evidence
2024-01-01 – 2024-06-3064094000 USD20250807Open filing evidence
2024-01-01 – 2024-03-3127889000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31143531000 USD20260226Open filing evidence
2023-07-01 – 2023-09-3037176000 USD20241112Open filing evidence
2023-01-01 – 2023-09-30116555000 USD20241112Open filing evidence
2023-04-01 – 2023-06-3045283000 USD20240808Open filing evidence
2023-01-01 – 2023-06-3079379000 USD20240808Open filing evidence
2023-01-01 – 2023-03-3134096000 USD20240509Open filing evidence
2022-01-01 – 2022-12-31143666000 USD20250225Open filing evidence
2021-01-01 – 2021-12-31112989000 USD20240229Open filing evidence

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=dna:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3027711000 USD20261109Open filing evidence
2026-01-01 – 2026-09-3067341000 USD20261109Open filing evidence
2026-04-01 – 2026-06-3020156000 USD20260806Open filing evidence
2026-01-01 – 2026-06-3039630000 USD20260806Open filing evidence
2026-01-01 – 2026-03-3119474000 USD20260507Open filing evidence
2025-07-01 – 2025-09-3029380000 USD20261109Open filing evidence
2025-01-01 – 2025-09-30106744000 USD20261109Open filing evidence
2025-04-01 – 2025-06-3039134000 USD20260806Open filing evidence
2025-01-01 – 2025-06-3077364000 USD20260806Open filing evidence
2025-01-01 – 2025-03-3138230000 USD20260507Open filing evidence